Emily Kimber is a journalist and editorial assistant, specializing in the field of pharmaceuticals and healthcare. With a focus on providing accurate and timely information to industry professionals, Emily's work has been featured in PMLiVE and PharmaTimes Media Ltd. Her articles cover a range of topics including drug approvals, clinical trial results, and regulatory updates.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Emily Kimber's articles mainly focus on healthcare and pharmaceutical industries, with an emphasis on press releases and data citations. To effectively reach out to her, consider offering newsworthy content related to drug trials, FDA approvals, advancements in biopharmaceuticals or cancer treatment. Furthermore, she may be interested in exclusive insights from industry experts regarding the latest developments within these areas.
Given Emily’s wide coverage of pharmaceutical companies and their activities, providing her with exclusive access to insider information about company developments or potential future trends could increase the chances of successful engagement.
As there is no specific geographic focus mentioned for Emily Kimber’s coverage area, it is advisable to tailor pitches that are globally relevant within the healthcare and pharmaceutical sectors.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Emily Kimber
The inflammatory skin disease affects approximately one in every 100 people in the US
The MHRA has appointed Anthony Harnden as Chair
By: Emily Kimber
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles
By: Caroline Phillips
The role of medical affairs (MA) and disease-state education has become essential in advancing patient care and supporting healthcare professionals (HCPs).
The day is aimed at raising awareness of severe allergic reaction and promoting prevention and management
By: Emily Kimber
The biotech will use the funding to drive sales of its first commercial product
Mahony will continue as the UK government’s Life Sciences Investment Envoy
Every day, inboxes and platforms are flooded with messages vying for attention in an already saturated healthcare communications landscape. Yet, most of this content is overlooked, because many strategies are built on assumptions rather than actionable insights.
This year’s Awards, held at the Sheraton Grand in London, included 17 categories
By: Emily Kimber
The genetic blood disorder affects more than 800,000 people globally
(833) 317-6278 
